← Back to topics

21-OHD CAH

21OHD diagnostic reports and evidence domains. The source matrix records whether findings address each domain.

Download CSV Atlas

Domain-specific / Insufficient Evidence

PaperYearStudy designReported sample sizeLinked case recordsReported findings Evidence source
Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of <i>CYP21A2</i> Gene. P001940 2024 Case series; molecular diagnostic study 3 — Molecular testing resolved complex CYP21A2 genotypes. The authors reported concordance with the severe phenotype in the study. p. 2 source_checked
Challenges in the Diagnosis of Simple-Virilizing Congenital Adrenal Hyperplasia: A Case Report. P002297 2022 Case report 1 — Repeat 17-OHP testing and imaging contributed to diagnosis after an initial non-diagnostic 17-OHP result. p. 1 source_checked
Three out of four: a case discussion on ambiguous genitalia. P001676 2008 Family case report 3 — The report used clinical and biochemical findings to establish a diagnosis. Molecular confirmation was unavailable. p. 2 source_checked
[A case of 21-hydroxylase deficiency and Bartter's syndrome associated with a balanced 6-9 translocation]. P001565 1986 Case report 1 — The report described a dual diagnosis. The accompanying Bartter-like disorder persisted despite treatment for 21OHD. p. 2 source_checked
Cite this page Data version · v1.4.0